Citations (31)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (5)
Rattanachai Chanchai, Rungsrit Kanjanavanit, Krit Leemasawat, Anong Amarittakomol, Paleerat Topaiboon & Arintaya Phrommintikul. (2018) Clinical tolerability of generic versus brand beta blockers in heart failure with reduced left ventricular ejection fraction: a retrospective cohort from heart failure clinic. Journal of Drug Assessment 7:1, pages 8-13.
Read now
Read now
Mario Del Tacca, Giuseppe Pasqualetti, Giovanni Gori, Pasquale Pepe, Antonello Di Paolo, Marianna Lastella, Ferdinando De Negri & Corrado Blandizzi. (2013) Comparative pharmacokinetic and pharmacodynamic evaluation of branded and generic formulations of meloxicam in healthy male volunteers. Therapeutics and Clinical Risk Management 9, pages 303-311.
Read now
Read now
Dong-Jin Jang, Taeyong Sim & Euichaul Oh. (2013) Formulation and optimization of spray-dried amlodipine solid dispersion for enhanced oral absorption. Drug Development and Industrial Pharmacy 39:7, pages 1133-1141.
Read now
Read now
Paul J Declerck & Steven Simoens. (2012) A European perspective on the market accessibility of biosimilars. Biosimilars 2, pages 33-40.
Read now
Read now
Paul J. Declerck, Feyza Darendeliler, Miklós Góth, Stanislava Kolouskova, Ioana Micle, Cees Noordam, Valentina Peterkova, Natalia N. Volevodz, Jiřina Zapletalová & Michael B. Ranke. (2010) Biosimilars: controversies as illustrated by rhGH. Current Medical Research and Opinion 26:5, pages 1219-1229.
Read now
Read now
Articles from other publishers (26)
Purnachandra Rao Avula, Ananda Kumar Chettupalli, Vivek Chauhan & Rajendra Kumar Jadi. (2023) Design, formulation, in-vitro and in-vivo pharmacokinetic evaluation of Nicardipine- nanostructured lipid carrier for transdermal drug delivery system. Materials Today: Proceedings.
Crossref
Crossref
André Cotia, Haliton Alves Oliveira Junior, Jessica Y. Matuoka & Ícaro Boszczowski. (2023) Clinical Equivalence between Generic Versus Branded Antibiotics: Systematic Review and Meta-Analysis. Antibiotics 12:5, pages 935.
Crossref
Crossref
R. Gomathi, R. Ganesamoorthy, S. Madeswaran, R. Parameswari, G. Vinitha & C. Ramki. (2023) Synthesis and characterization of cyclohexylammonium hydrogen maleate hemihydrate single crystal and its anti-bacterial activities. Materials Today: Proceedings.
Crossref
Crossref
Georges Hatem, Nare Navasardyan, Elsa Lahoud, Sanaa Awada, Rana Itani, Roula Ajrouche & Mathijs Goossens. (2022) Predictors of substitution to generic drugs and physicians’ perceived exclusivity of substitution: A cross sectional survey among physicians. Journal of Generic Medicines: The Business Journal for the Generic Medicines Sector 19:1, pages 23-32.
Crossref
Crossref
Kyung-Bok Son. (2022) Who initiates price competition when generic entrants are introduced into the South Korean pharmaceutical market?. Frontiers in Public Health 10.
Crossref
Crossref
Gulam Mustafa, Md Ali Mujtaba, Sabna Kotta, Abdullah Habeeballah, Nabil A. Alhakamy, Hibah M. Aldawsari, Shahid Karim & Shadab Md. 2022. Regulatory Affairs in the Pharmaceutical Industry. Regulatory Affairs in the Pharmaceutical Industry
215
240
.
Jacinthe Leclerc, Claudia Blais, Louis Rochette, Denis Hamel, Line Guénette, Claudia Beaudoin & Paul Poirier. (2020) Public Health Outcomes May Differ After Switching from Brand-Name to Generic Angiotensin II Receptor Blockers. Drugs in R&D 20:2, pages 135-145.
Crossref
Crossref
Maria Agudelo, Carlos A. Rodriguez, Andres F. Zuluaga & Omar Vesga. (2019) Nontherapeutic equivalence of a generic product of imipenem-cilastatin is caused more by chemical instability of the active pharmaceutical ingredient (imipenem) than by its substandard amount of cilastatin. PLOS ONE 14:2, pages e0211096.
Crossref
Crossref
Hema Kapoor, Mohd. Aqil, Syed Sarim Imam, Yasmin Sultana & Asgar Ali. (2019) Formulation of amlodipine nano lipid carrier: Formulation design, physicochemical and transdermal absorption investigation. Journal of Drug Delivery Science and Technology 49, pages 209-218.
Crossref
Crossref
L Pasina, SAM Urru & S Mandelli. (2016) Why do patients have doubts about generic drugs in Italy?. European Journal of Clinical Pharmacology.
Crossref
Crossref
Yang Yu, Steven Teerenstra, Cees Neef, David Burger & Marc Maliepaard. (2016) A comparison of the intrasubject variation in drug exposure between generic and brand-name drugs: a retrospective analysis of replicate design trials. British Journal of Clinical Pharmacology 81:4, pages 667-678.
Crossref
Crossref
A. O’Leary, C. Usher, M. Lynch, M. Hall, L. Hemeryk, S. Spillane, P. Gallagher & M. Barry. (2015) Generic medicines and generic substitution: contrasting perspectives of stakeholders in Ireland. BMC Research Notes 8:1.
Crossref
Crossref
Aleksandra Drozdowska & Tomasz Hermanowski. (2015) Solution-driven approaches to generic substitution challenges - a survey among international experts. Fundamental & Clinical Pharmacology 29:6, pages 592-603.
Crossref
Crossref
Nazila Yousefi, Gholamhossein Mehralian, Farzad Peiravian & Samaneh NourMohammadi. (2015) Consumers’ perception of generic substitution in Iran. International Journal of Clinical Pharmacy 37:3, pages 497-503.
Crossref
Crossref
Daniele Piovani, Antonio Clavenna, Massimo Cartabia, Angela Bortolotti, Ida Fortino, Luca Merlino & Maurizio Bonati. (2015) Comparing recurrent antibiotic prescriptions in children treated with a brand name or a generic formulation. Pharmacoepidemiology and Drug Safety 24:2, pages 121-128.
Crossref
Crossref
Y Yu, S Teerenstra, F Vanmolkot, C Neef, D Burger & M Maliepaard. (2013) Interchangeability of Gabapentin Generic Formulations in the Netherlands: A Comparative Bioavailability Study. Clinical Pharmacology & Therapeutics 94:4, pages 519-524.
Crossref
Crossref
Jette Rathe, Pia Larsen, Morten Andersen, Maja Paulsen, Dorte Jarbøl, Janus Thomsen & Jens Soendergaard. (2013) Associations between generic substitution and patients' attitudes, beliefs and experiences. European Journal of Clinical Pharmacology 69:10, pages 1827-1836.
Crossref
Crossref
Rhonda M. Cooper-DeHoff & William J. Elliott. (2013) Generic Drugs for Hypertension: Are They Really Equivalent?. Current Hypertension Reports 15:4, pages 340-345.
Crossref
Crossref
Marta Herranz, Susana Morales-Alcelay, Ma Teresa Corredera-Hernández, José María de la Torre-Alvarado, Antonio Blázquez-Pérez, Ma Luisa Suárez-Gea, Covadonga Álvarez & Alfredo García-Arieta. (2012) Bioequivalence between generic tacrolimus products marketed in Spain by adjusted indirect comparison. European Journal of Clinical Pharmacology 69:5, pages 1157-1162.
Crossref
Crossref
Hans C Ebbers, Stacy A Crow, Arnold G Vulto & Huub Schellekens. (2012) Interchangeability, immunogenicity and biosimilars. Nature Biotechnology 30:12, pages 1186-1190.
Crossref
Crossref
G. W.'t Jong. (2012) In Vivo Inferiority of Generic Product Compared With Branded Vancomycin: A Paradigm Shift. Therapeutic Drug Monitoring 34:1, pages 2-3.
Crossref
Crossref
Hans C. Ebbers, Toine Pieters, Hubert G. Leufkens & Huub Schellekens. (2012) Effective pharmaceutical regulation needs alignment with doctors. Drug Discovery Today 17:3-4, pages 100-103.
Crossref
Crossref
Hee Youn ChoiJae Woo KimHyeong-Seok LimSang-Heon ChoJong-Lyul GhimSangmin ChoeJin Ah JungJonglae LimKyun-Seop Bae. (2012) Comparison of Pharmacokinetic Characteristics and the Safety between Amlodipine Maleate Tablet 5 mg and Amlodipine Besylate Tablet 5 mg. Journal of Korean Society for Clinical Pharmacology and Therapeutics 20:1, pages 42.
Crossref
Crossref
Atholl Johnston, Roland Asmar, Björn Dahlöf, Kate Hill, David Albert Jones, Jens Jordan, Michael Livingston, Graham MacGregor, Michael Sobanja, Panagiotis Stafylas, Enrico Agabiti Rosei & José Zamorano. (2011) Generic and therapeutic substitution: a viewpoint on achieving best practice in Europe. British Journal of Clinical Pharmacology 72:5, pages 727-730.
Crossref
Crossref
Michael A Veronin. (2011) Should we have concerns with generic versus brand antimicrobial drugs? A review of issues. Journal of Pharmaceutical Health Services Research 2:3, pages 135-150.
Crossref
Crossref
Antoni Sicras Mainar & Ruth Navarro Artieda. (2010) Influencia de la sustitución de medicamentos de marca por genéricos en el cumplimiento terapéutico de la hipertensión arterial y la dislipidemia. Gaceta Sanitaria 24:6, pages 473-482.
Crossref
Crossref